4.5 Review

The multi-faceted role of mitochondria in the pathology of Parkinson's disease

Journal

JOURNAL OF NEUROCHEMISTRY
Volume 156, Issue 6, Pages 715-752

Publisher

WILEY
DOI: 10.1111/jnc.15154

Keywords

animal models; cell and molecular mechanisms; genetic; familial Parkinson's disease; human studies; mitochondria; mitochondria enhancers and small molecules; Parkinson's disease

Funding

  1. Natural Sciences and Engineering Research Council of Canada [480530]
  2. Michael J. Fox Foundation for Parkinson's Research

Ask authors/readers for more resources

Mitochondria play a crucial role in neuronal function, regulating protein synthesis and synaptic plasticity. Dysfunction of mitochondria has been associated with several neurodegenerative diseases, including Parkinson's disease.
Mitochondria are essential for neuronal function. They produce ATP to meet energy demands, regulate homeostasis of ion levels such as calcium and regulate reactive oxygen species that cause oxidative cellular stress. Mitochondria have also been shown to regulate protein synthesis within themselves, as well as within the nucleus, and also influence synaptic plasticity. These roles are especially important for neurons, which have higher energy demands and greater susceptibility to stress. Dysfunction of mitochondria has been associated with several neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, Huntington's disease, Glaucoma and Amyotrophic Lateral Sclerosis. The focus of this review is on how and why mitochondrial function is linked to the pathology of Parkinson's disease (PD). Many of the PD-linked genetic mutations which have been identified result in dysfunctional mitochondria, through a wide-spread number of mechanisms. In this review, we describe how susceptible neurons are predisposed to be vulnerable to the toxic events that occur during the neurodegenerative process of PD, and how mitochondria are central to these pathways. We also discuss ways in which proteins linked with familial PD control mitochondrial function, both physiologically and pathologically, along with their implications in genome-wide association studies and risk assessment. Finally, we review potential strategies for disease modification through mitochondrial enhancement. Ultimately, agents capable of both improving and/or restoring mitochondrial function, either alone, or in conjunction with other disease-modifying agents may halt or slow the progression of neurodegeneration in Parkinson's disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available